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causes the   pathological symptoms of AD (e.g., Price and Morris, 
2004). Indeed, it was recently proposed that Aβ oligomers are the 
main neurotoxins in AD, whose activity is directly linked to tau 
hyperphosphorylation (De Felice et al., 2008).
A striking feature of the amyloid plaques associated with AD, 
particularly during the early stages of the disease, is that there are 
remarkable differences in their density across the distinct cortical 
areas and layers (e.g., Terry and Katzman, 1983; Kemper, 1984; 
Kirkpatrick, 1985; Pearson et al., 1985; Rogers and Morrison, 1985; 
Duyckaerts et al., 1986; Lewis et al., 1987; Rafalowska et al., 1988; 
Arnold et al., 1991; Lippa et al., 1992; Gomez-Isla et al., 1996; Kuljis 
and Tikoo, 1997; Thal et al., 2000). Plaques have been classiﬁ  ed into 
several types according to their morphological criteria and staining 
properties (e.g., Wisniewski et al., 1989; Delaere et al., 1991; Thal 
et al., 2000) and signiﬁ  cantly, these different types of plaques are 
heterogeneously distributed throughout the cerebral cortex (e.g., 
Kirkpatrick, 1985; Rogers and Morrison, 1985; Duyckaerts et al., 
1986; Lewis et al., 1987; Rafalowska et al., 1988). Since plaques have 
traditionally been described in the neuropil, it is generally thought 
that the neurotoxic effects of Aβ deposits affect axons and dendrites. 
However, other authors have indicated that plaques come into con-
tact with, or even contain, neuronal cell bodies (Allsop et al., 1989; 
Pappolla et al., 1991; Cummings et al., 1993; Armstrong, 1995). 
Thus, since plaques may appear in the neuropil or in direct asso-
ciation with neuronal cell bodies, the relative abundance of these 
two types of plaques is likely to inﬂ  uence the alterations to speciﬁ  c 
INTRODUCTION
Alzheimer’s disease (AD) is the most common form of senile 
dementia and it is characterized by a progressive loss of memory, 
coupled with a deterioration of behavioral and cognitive func-
tions. AD patients display cerebral cortical atrophy, particularly 
in the temporal and frontal lobes. Among the main pathological 
hallmarks of this disease in the brain are: the formation of plaques 
of extracellular ﬁ  brillar amyloid beta peptide (Aβ); the appear-
ance of the so-called neuropil threads, intraneuronal neuroﬁ  brillary 
tangles of aggregated hyperphosphorylated tau (in the cell body as 
well as in the dendritic and axonal processes); and elevated levels 
of soluble Aβ oligomers (Glenner and Wong, 1984; Masters et al., 
1985; Grundke-Iqbal et al., 1986; Ihara et al., 1986; Kosik et al., 
1986; Goedert et al., 1988). Plaques and neuroﬁ  brillary tangles 
are mostly found in the cerebral cortex (entorhinal cortex, hip-
pocampal formation and neocortex), where both their number 
and the proportion of the cortex affected increases progressively 
as the disease advances (Braak and Braak, 1991; Dickson, 1997; 
Thal et al., 2002). However, these pathological changes can also be 
observed in subcortical structures such as the amygdala, nucleus 
basalis, thalamus, locus coeruleus and raphe nuclei, particularly 
during the late stages of AD (e.g., Esiri et al., 1997). Thus, multiple 
neuronal circuits and neurotransmitter systems may be altered in 
the brain of AD patients. One hypothesis regarding the patho-
genesis of AD is the so-called “amyloid hypothesis”, whereby an 
accumulation of the neurotoxic Aβ peptide in the cerebral cortex 
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synaptic circuits that may occur in AD. For example, pyramidal 
cells are the most common type of cortical neuron and different 
regions of the pyramidal cells are innervated by different axonal 
systems. In general, all axon terminals forming synapses with the 
perisomatic region of pyramidal cells are GABAergic and they origi-
nate from two main types of interneurons: basket cells and chan-
delier cells. The dendrites in the neuropil establish synapses with 
a larger variety of axonal systems, including: glutamatergic axons 
(mainly originating from pyramidal cells and thalamic afferents); 
GABAergic/peptidergic axons (originating from various types of 
axo-dendritic interneurons); and noradrenergic, dopaminergic, 
serotoninergic and cholinergic axons (arising in the brainstem 
and basal forebrain: DeFelipe, 2002).
This situation suggests that the plaques in the neuropil will 
produce different alterations to synaptic circuits than those asso-
ciated with neuronal somata. However, the relationship between 
plaques and neuronal somata has not been directly addressed 
despite the numerous neuropathological studies that have been 
performed. Finally, different transgenic mice models of AD have 
been developed that are useful to investigate some aspects of the 
disease, as well as to evaluate the therapeutic potential of various 
drugs and treatments that for obvious ethical reasons cannot be 
tested in human beings (review in McGowan et al., 2006; Eriksen 
and Janus, 2007). In one of these mutants the amyloid pathology 
displayed is due to the co-expression of a chimeric mouse/human 
amyloid precursor protein (Mo/HuAPP695swe) and a mutant 
human presenilin 1 (PS1-dE9) protein, both of which are involved 
in familial forms of AD. The peculiarity of these double trans-
genic (APP/PS1) mice is that they do not develop the neuroﬁ  bril-
lary changes that are also typical of AD (Irizarry et al., 1997a,b). 
Therefore, this mouse model is useful to examine the effect of 
Aβ overproduction and deposition on the brain, independently 
of the neuroﬁ  brillary alterations. Here, we have used a variety of 
conventional light, electron and confocal microscopy techniques 
to analyze the relationship of plaques with neuronal somata in the 
cerebral cortex of AD patients and transgenic AD mice. We found 
that the membrane surface of the neuronal somata in contact with 
the plaques lacked GABAergic axo-somatic synapses. These results 
suggest that plaques modify the circuits in a more selective manner 
than previously thought.
MATERIALS AND METHODS
HUMAN BRAIN TISSUE
Human brain tissue from eight patients with AD (aged 80–94, 
average 84) was obtained from the Institut Neuropatologia, Servei 
Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge 
(Barcelona, Spain). In addition, control human brain tissue was 
obtained at autopsy from seven individuals (aged 23–69, average 53) 
that were free of any neurological or psychiatric disease (kindly sup-
plied by Dr. R. Alcaraz, Forensic Pathology Service, Basque Institute 
of Legal Medicine, Bilbao, Spain: Table 1).
Following a neuropathological examination, the AD stages were 
deﬁ  ned according to Braak and Braak (1991) (Table 2). In all cases, 
the time between death and tissue processing was between 1.5 and 
3 h. Upon removal, the brain tissue was immediately ﬁ  xed in cold 
4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4 and 
after 2 h, the tissue was cut into small blocks and post-ﬁ  xed in 
the same ﬁ  xative for 24–48 h at 4°C. Brain samples were obtai-
ned following the guidelines and approval by the Institutional 
Ethical Committee.
The tissue was obtained from area 4 (motor primary cortex) in 
the precentral gyrus; area 10 (frontal cortex) in the most rostral 
portion of the superior frontal gyrus and the middle frontal gyrus; 
area 17 (striate cortex) located within the calcarine sulcus; area 18 
(second visual area) located immediately adjacent to area 17; areas 
20 and 21 (the inferior temporal cortex) in the medial and inferior 
temporal gyri, respectively; area 24 (the cingulate cortex) which 
occupies most of the anterior cingulate gyrus in an arc around the 
genu of corpus callosum and that has a poorly deﬁ  ned layer IV. 
Blocks from the different (Brodmann’s) areas of the cortex were 
selected from each brain according to their surface anatomy based 
on the patterns of the gyri and sulci. Furthermore, in this study 
we included the following regions of the hippocampal formation 
and adjacent cortex: the dentate gyrus; the hippocampus proper 
(Cornu Ammonis ﬁ  elds CA1, CA2 and CA3/CA4); the subiculum, 
the entorhinal cortex; and the perirhinal cortex. In all cases, the iden-
tiﬁ  cation of each cortical area was later conﬁ  rmed by analyzing their 
distinctive cytoarchitectonic features in Nissl-stained sections.
After ﬁ  xation, all the specimens were immersed in graded 
sucrose solutions and they were stored in a cryoprotectant solu-
tion at −20°C. Serial sections (50 µm) of the cortical tissue were 
obtained using a vibratome, and the sections from each region and 
case were batch-processed for immunocytochemical staining. The 
sections immediately adjacent to those stained immunocytochemi-
cally were Nissl-stained in order to identify the cortical areas and 
the laminar boundaries.
Table 1 | Summary of case data.
  Age  Gender  Postmortem   Cause of death
     delay  (hour)
AD PATIENTS
P1 80  Female 2  –
P2 94  Female 1.5  Pulmonary  tuberculosis
P3 82  Female 3  Pneumonia
P4 80  Female 3  Pseudomembranous
       colitis  + sepsis + pancreatic
       adenocarcinoma
P5 85  Male  2  Pneumonia  + interstitial
       pneumonitis
P6 88  Female 2  Bronchopneumonia
P7 91  Male  3  Hepatocarcinoma
P8 72  Male  2  Bronchopneumonia
CONTROL CASES
C1 23  Male  2–3  Trafﬁ  c accident
C2 49  Male  2–3  Trafﬁ  c accident
C3 69  Male  2–3  Trafﬁ  c accident
C4 63  Female 3  Trafﬁ  c accident
C5 59  Male  1.5–2  Trafﬁ  c accident
C6 40  Male  3  Trafﬁ  c accident
C7 66  Male  3  Trafﬁ  c accidentFrontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  3
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TRANSGENIC MOUSE BRAIN TISSUE
In this study, we used the B6C3-Tg 85DBo/J transgenic mice 
(APPswe, PSEN1dE9) expressing a chimeric mouse/human 
amyloid precursor protein (Mo/HuAPP695swe) and a mutant 
human presenilin 1 (PS1-dE9) in CNS neurons (from The 
Jackson Laboratory, Bar Harbor, ME, USA). Six 12-month-old 
male mice were anaesthetized with sodium pentobarbital and 
perfused through the heart with physiological saline, followed by 
4% paraformaldehyde in PB. The brain was then removed and 
post-ﬁ  xed for 24 h at 4°C. Coronal sections (50 µm) were obtained 
with the aid of a vibratome. In these animals, the analysis was 
focused on the granular neocortical areas between bregma −1.10 
and −3.00 mm (Hof et al., 2000a), areas including: the dorsal part 
of the auditory cortex; the primary auditory cortex; the ventral 
part of the auditory cortex; the anteromedial visceral cortex; the 
primary visceral cortex; the primary somatosensory cortex; the 
secondary somatosensory cortex; the anteromedial visceral cortex; 
the primary visceral cortex; and the visual cortex (rostrolateral 
and anterolateral area). The experiments were approved by the 
ethical institutional committee according to National Institutes 
of Health guidelines.
IMMUNOHISTOCHEMISTRY
Free-ﬂ  oating sections were pre-treated in 1% H2O2 for 30 min to 
inactivate the endogenous peroxidase. Subsequently, the sections 
were incubated for 1 h in PB with 0.25% Triton-X and 3% normal 
horse serum (Vector Laboratories Inc., Burlingame, CA, USA). 
Thereafter, two methods were used to examine the relationship 
between neuronal cell somata and the plaques: combined ﬂ  uo-
rescence immunohistochemistry and histochemical staining; or 
dual peroxidase immunohistochemistry in the same sections.
Fluorescence immunohistochemistry and histochemistry
Dual labeling. Sections were double stained using a mouse 
antibody against the neuron speciﬁ  c nuclear protein (NeuN, 
1:2000; Chemicon, Temecula, CA, USA) to label the neurons, and 
Thioﬂ  avine-S to label the plaques. The sections were incubated 
overnight at 4°C in a solution containing anti-NeuN and then for 
2 h at room temperature with a biotinylated horse anti-mouse IgG 
(1:200, Vector Laboratories). After rinsing in PB, the sections were 
incubated for 2 h at room temperature in Alexa ﬂ  uor 594 cou-
pled streptavidin (1:1000; Molecular Probes, Eugene, OR, USA). 
Thereafter, sections were stained for 10 min in a 1% solution of 
Thioﬂ  avine-S and quickly rinsed with water. The sections were 
then rapidly rinsed with three changes of 100, 70, 50% ethanol, 
and then in PB. Finally, the sections were washed and mounted 
with ProLong Gold Antifade Reagent (Invitrogen Corporation, 
Carlsbad, CA, USA) and examined on a LeicaDMI 600B confocal 
laser scanning system equipped with an argon/krypton mixed 
gas laser with excitation peaks at 498 and 594 nm. The Alexa 
594 and Thioﬂ  avine-S ﬂ  uorescence was recorded through sepa-
rate channels. In order to examine the 3D relationship between 
 neuronal cell somata and plaques, we obtained image stacks (phys-
ical size 76.88 mm × 76.88 mm, logical size 1024 × 1024 pixels) 
Table 2 | Neuropathological assessment for the accumulation of neuroﬁ  brillary tangles (immunostained for H-tau) and plaques (immunostained for 
amyloid-β: Aβ).
Cortical  Patients  P1  P2 P3  P4 P5  P6  P7  P8
areas
  Diagnosis  AD IV/B  AD V/C  AD III/B  AD III   AD III/A   AD III (TAD*)   AD III/A   AD I (TAD*) examined
          (TAD*)  and AGD  and AGD  and AGD  and AGD
Entorhinal region  H-tau  +++  +++  +++  +++  +++  +++  +++ 0
outer layers  Aβ  +  +  ++ 0  0  0  0  0
Entorhinal region   H-tau  +++  +++  +++  +++  ++  +++  +++ 0
inner layers  Aβ  +  +  ++ 0  0  0  0  0
Hippocampus H-tau  +++  +++  ++  ++  ++  ++ 0  0
 A β  +  + 0  0 0  0  0  0
Transentorhinal H-tau  +++  +++  +++  +++  +++  +++  +++  ++
region Aβ  ++  ++  ++ 0  0  0  + 0
Occipito-temporal   H-tau  NA  +++  ++  +++  +++  ++  ++ 0
region (areas 36)  Aβ NA  ++  ++ 0  + 0  + 0
Temporal cortex   H-tau  NA  NA  0  0  0  0  0  0
(area 22)  Aβ NA  NA  + 0  0  0  0  0
Frontal cortex   H-tau  NA  +++ 0  0  0  0  0  0
(area 8)  Aβ NA  +++  ++ 0  0  0  + 0
Occipital cortex   H-tau  NA  +++ 0  0  0  + 0  0
(area 17)  Aβ NA  +++  + 0  0  0  0  0
Occipital cortex  H-tau  NA  +++ 0  0  0  0  0  0
(areas 18/19)  Aβ NA  +++  + 0  + 0  0  0
The overall amount of neuroﬁ  brillary tangles and Aβ is graded and labeled zero (0) with no discernible change, (+) with small, (++) moderate, and (+++) large 
numbers of NFT and Aβ. AGD, argyrophilic grain disease; NA, material not available; TAD*, tangle-predominant variant of Alzheimer’s disease; AD staging follows 
the nomenclature of Braak and Braak (1991).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  4
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that consisted of 19–43 image planes. A 63× glycerol-immersion 
lens was used (NA, 1.3, working distance, 280 mm, refraction 
index, 1.45) with a calculated optimal zoom factor 3.2 and with 
z-step 0.24 µm.
Triple labeling. Some sections were triple stained using a mouse 
antibody against NeuN (1:2000), Thioﬂ  avine-S and two different 
antibodies to visualize GABAergic terminals: a rabbit antiserum 
raised against the high-afﬁ  nity GABA plasma membrane trans-
porter GAT1 (1:500; Chemicon International, Temecula, CA, 
USA) or a rabbit antiserum raised against the vesicular GABA 
transporter (VGAT) (1:2000; Synaptic Systems, Goettingen, 
Germany). The sections were incubated overnight at 4°C in a 
solution containing anti-NeuN and either VGAT or GABA trans-
porter 1 (GAT-1) and then for 2 h at room temperature with a 
biotinylated goat anti-  rabbit IgG (1:200, Vector Laboratories). 
After rinsing in PB, the sections were incubated for 2  h at 
room temperature in Alexa ﬂ  uor goat-anti mouse 594 (1:2000; 
Molecular Probes) and streptavidin coupled to Alexa ﬂ  uor 488 
(1:1000; Molecular Probes). Thereafter, sections were stained for 
Thioﬂ  avine-S under the same conditions indicated above. After 
rinsing in PB, the sections were treated with Autoﬂ  uorescence 
Eliminator Reagent (Chemicon International) to reduce or elimi-
nate lipofuscin like-autoﬂ  uorescence without adversely affect-
ing other ﬂ  uorescent label in the sections. Finally, sections were 
washed and mounted with ProLong Gold Antifade Reagent and 
examined on the LeicaDMI 600B confocal laser scanning system. 
The Alexa 594, Alexa 488 and Thioﬂ  avine-S ﬂ  uorescence was 
recorded through separate  channels. Since thioﬂ  avine ﬂ  uoresces 
in the blue–green range (380–480 nm), it was recorded in blue 
to differentiate it from Alexa 488. The 3D relationship between 
neuronal cell somata, GABAergic terminals and plaques, was 
analyzed using image stacks (physical size 123  µm  × 123 µm 
and 98.4 µm × 98.4 µm for human and transgenic mice sections, 
respectively, and logical size 1024 × 1024 pixels) that consisted 
of 17–55 image planes. A 63× glycerol-  immersion lens was used 
(NA, 1.3, working distance, 280 mm, refraction index, 1.45) with 
a calculated optimal zoom factor 2.5 and 2.0 (for human and 
transgenic mice sections, respectively) and with z-step 0.2 µm.
Dual peroxidase immunohistochemistry
Sections from human and mouse tissue were incubated for 20 
min in formic acid 55% in PB. Then the sections were incubated 
overnight at 4°C with a mouse antibody against Aβ (clone 6F/3D 
diluted 1:50; Dako, Glostrup, Denmark) and a mouse antibody 
against NeuN under the same conditions indicated above. The 
following day, the sections were rinsed and incubated for 1 h 
with a biotinylated horse anti-mouse IgG (1:200; Vector), then 
for 30 min in a Vectastain ABC immunoperoxidase kit (Vector). 
Finally, the antibodies were visualized with the 3,3′-diaminoben-
zidine (DAB) tetrahydrochloride chromogen (Sigma-Aldrich, St 
Louis, MO, USA) and they were then dehydrated, cleared with 
xylene and coverslipped.
For all immunocytochemical procedures, the controls involved 
processing selected sections either after replacing the primary anti-
body with normal serum, omitting the secondary antibody, or by 
replacing the secondary antibody with an inappropriate secondary 
antibody. No signiﬁ  cant staining was detected under these control 
conditions.
ELECTRON MICROSCOPY
Human and mouse sections adjacent to those used for histopatho-
logical assessment were processed for electron microscopy. These 
sections were post-ﬁ  xed in 2% glutaraldehyde in PB for 1 h, treated 
with 1% osmium tetroxide, dehydrated and ﬂ  at embedded in Araldite 
resin. Plastic-embedded sections were studied using a correlative 
light and electron microscopy method that was described in detail 
elsewhere (DeFelipe and Fairen, 1993). Brieﬂ  y, sections were pho-
tographed under the light microscope and then serially cut into 
semi-thin (2 µm thick) sections with a Reichert ultramicrotome. 
The semi-thin sections were stained with 1% toluidine blue in 1% 
borax, they were examined under the light microscope, and then 
photographed to locate the region of interest. Selected semi-thin sec-
tions were further sectioned into serial ultrathin sections (50–70 nm 
thick) with a diamond knife using a Reichert ultramicrotome. The 
ultrathin sections were collected on formvar-coated, single-slot nickel 
grids, and stained with uranyl acetate and lead citrate. Digital pictures 
were captured at different magniﬁ  cations in a Jeol 150 transmission 
electron microscope (JEOL USA, Inc., Peabody, MA, USA) equipped 
with a SIS Megaview III CCD digital camera.
QUANTITATIVE AND STATISTICAL ANALYSES
A BX51 Olympus microscope equipped with a motorized 
stage, a DP70 digital camera and the Neurolucida package 
(MicroBrightField, Williston, VT, USA), was used to count the 
different types of plaques in sections double stained for Aβ and 
NeuN. Cortical layers were traced with the 4× objective and using 
the Neurolucida package, the complete surface of the previously 
deﬁ  ned counting ﬁ  elds was scanned with a 40× objective in succes-
sive and non-overlapping frames of 17250 µm2. The white matter 
(WM) in the neocortex was divided into the superﬁ  cial and deep 
white matter (SWM and DWM, respectively) with an arbitrary 
thickness of 175 µm for each layer. The SWM extended from just 
below layer VI to a depth of 175 µm. The upper limit of the DWM 
was situated at a distance of 225 µm from the SWM (i.e., 400 µm 
below of layer VI) and the lower limit was situated at a depth 175 µm 
below its upper limit. All the plaques were recorded and classiﬁ  ed 
as diffuse or neuritic (including non-cored and cored; see Section 
“Results”). In addition, the plaques were subdivided depending on 
whether they were in contact or not with neurons. A neuron was 
considered in contact with a plaque when at least a portion of the 
soma was observed in close apposition with the plaque in the same 
focal plane. Furthermore, when the plaques were in contact with 
neurons we recorded the number of these neurons and whether 
they were at the periphery or within the plaques.
Statistical comparisons between the different types of plaques in 
each layer were performed using one-way ANOVA or the Kruskal–
Wallis non-parametric test, depending on whether the datasets ﬁ  t-
ted a normal distribution and passed the test for homogeneity of 
variances. The data are presented as the mean ± SEM. All statistical 
studies were performed with the aid of the GraphPad Prism 5.1 
statistical package (Prism, San Diego, CA, USA).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  5
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To generate the ﬁ  gures, light microscopy images were   captured 
using a digital camera (Olympus DP50) attached to an Olympus light 
microscope and Adobe Photoshop CS3 software was used to gener-
ate the ﬁ  gure plates (Adobe Systems Inc., San Jose, CA, USA).
RESULTS
Plaques were observed in all cortical layers and sub-cortical WM 
of the neocortex, as well as in the hippocampal formation and 
adjacent cortex. Detailed quantitative analyses were performed on 
tissue from three AD cases (Figures 1–3) and six transgenic mice 
(Figure 4). Despite the variability in the size of the different types 
of plaques, around 80% were between 200 and 1200 µm2 in humans 
and between 100 and 700 µm2 in mouse. As described previously 
(Jaffar et al., 2001), the appearance of the plaques was similar in 
humans and mice (compare Figures 1G–L with Figures 4C–E).
TYPES OF PLAQUES
We could distinguish two main types of plaques in sections immuo-
cytochemically stained for Aβ using DAB as the chromogen: Type 
1 plaques that contain irregular extracellular deposits of lightly 
stained Aβ with no large punctate structures (Figures 1G and 4C); 
and Type 2 plaques that are characterized by Aβ deposits and large 
punctate structures (Figures 1I and 4E). When analyzed by correla-
tive light and electron microscopy (see below), these large punctate 
structures represent dystrophic neurites. Thus, on the basis of previ-
ous studies (e.g., Bancher et al., 1989; Delaere et al., 1991; Thal et al., 
2000, 2006) we called the Type 1 and Type 2 plaques, diffuse and 
neuritic plaques, respectively. Furthermore, some neuritic plaques 
contained a round, dense and darkly stained central region, or a 
nucleus of Aβ that was frequently surrounded by a lightly stained 
halo. This halo consisted of amorphous material with some large 
and irregular punctate elements (Figures 1H and 4D). Hence, neu-
ritic plaques were sub-divided into “cored” (classic plaques) and 
“non-cored” neuritic plaques. Plaques were evident in the neuropil 
(Figures 1G–I and 4C) or associated with neurons (in contact with 
or contained within neurons, Figures 1J–L and 4D,E).
Thus, in the present study the main objective was to examine the 
spatial relationship of the plaques with neurons, their perisomatic 
GABAergic innervation and the ultrastructural characteristics of 
this relationship.
THE RELATIONSHIP BETWEEN PLAQUES AND NEURONS
In order to study a relatively large number of plaques and their 
relationship with neurons, we examined at the light microscopy 
level sections that were processed for dual peroxidase immuno-
histochemistry for anti-Aβ and NeuN in the neocortex. Here, we 
shall ﬁ  rst describe the results from the human brain tissue before 
addressing the data obtained from the transgenic mice.
Conventional light microscopy studies
A total of 2742 plaques (diffuse, 25%; non-cored neuritic, 41%; 
cored neuritic, 34%) were examined in the neocortex of three AD 
cases. In all cases, plaques were frequently associated with neurons 
in layers II–VI since 36% were localized in the neuropil and the 
remaining 64% were observed in contact with neurons (Figure 5A). 
However, in layer I and in the SWM the percentage of plaques 
observed in the neuropil was greater than those found in layers 
II–VI (86 and 65%, respectively). Moreover, in layers II–VI, 70% of 
cored neuritic plaques and 73% of diffuse plaques were in contact 
with neurons, whereas neurons were only in contact with 51% of 
non-cored neuritic plaques. In layer I and SWM, the percentage of 
diffuse, non-cored neuritic and core neuritic plaques in contact with 
neurons was 28 and 31%, 13 and 22%, and 8 and 20%, respectively 
(Figure 5A). Signiﬁ  cant differences were found in the representation 
of each plaque type in the distinct cortical layers (Table 3).
Of the plaques associated with neurons, 68% were in contact with 
neurons but not inside the plaques while at least one neuron was found 
inside the plaque in the remaining 32% of plaques. Of the plaques 
with no neurons inside them, most displayed one to three neurons 
(92%) in contact with the plaques and less frequently (8%), there were 
up to nine neurons associated. With regards the plaques containing 
neurons, most of them had one to three neurons within the plaques 
(90%) while the remainder contained four neurons (10%).
In order to investigate possible variations in the percentage 
of plaques in contact with neurons in different cortical areas in 
patients with different stages of the disease, we compared patients 
P1, P2 and P3 that were classiﬁ  ed as IV/B, V/C and III/B, respec-
tively, according to Braak and Braak (1991) (Table 2). As shown in 
Figure 5B, no signiﬁ  cant differences were observed in the propor-
tion of the plaques that were in contact with neurons in different 
cortical regions and patients.
We also quantiﬁ  ed the relationship between plaques and the 
neuronal cell bodies in each cortical layer in six transgenic mice 
(Figures 4 and 5C). A total of 538 plaques were examined (18% 
diffuse, 72% non-cored neuritic, 11% cored neuritic). In layers 
II–VI, 52% of plaques were in contact with neurons whereas in 
layer I this percentage was 17%. When the relationship between the 
different types of plaques and neuronal cell bodies was examined, 
the non-cored plaques were preferentially associated with neurons 
(57%) while only 41% of cored neuritic plaques and 34% of diffuse 
plaques were in contact with neurons. Indeed, there were signiﬁ  cant 
differences between the different types of plaques in the distinct 
layers (Table 4). Of the plaques in contact with neurons, 81% had 
one to three neurons at the periphery of the plaque, whereas the 
remaining 19% of plaques had neurons both at the periphery and 
within (one to three neurons) the plaque.
DIMINISHED PERISOMATIC GABAergic TERMINALS ON NEURONS 
ADJACENT TO PLAQUES
Confocal microscopy studies
When the spatial association of neurons and plaques was studied 
across confocal z-series, staining the same sections for both NeuN to 
visualize neurons and for Thioﬂ  avine-S to visualize plaques, it was 
clear that some neuronal somata and/or their proximal processes 
were in intimate contact with the plaques (Figure 6), suggesting that 
no perisomatic boutons were present. Since virtually all cell somata 
and proximal processes in layers II–VI are outlined by GABAergic 
terminals (Ribak, 1978; see Merchan-Perez et al., 2009 for a recent 
study), we examined whether the perisomatic innervation of neu-
rons in contact with plaques was altered in the human and mouse 
cerebral cortex. We used triple ﬂ  uorescence confocal microscopy 
to analyze neurons immunohistochemically labeled with NeuN Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  6
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FIGURE 1 | (A–C) Low power photomicrographs from sections double 
stained for anti-Aβ and NeuN, showing the pattern of immunostaining in 
layers I–VI of different cortical areas from patient P3. (A) Visual cortex, 
(B) cingulate cortex, (C) frontal cortex. (D–F) Higher magniﬁ  cation of boxed 
areas in (A–C), respectively. (G–L) High-power photomicrographs showing 
different types of plaques and their relationship with neurons: (G–I) diffuse, 
cored neuritic and non-cored neuritic plaques, respectively, in the neuropil. (J–
L) diffuse, cored neuritic and non-cored neuritic plaques, respectively, in 
contact with neurons. Scale bar, 100 µm in (A–C); 20 µm in (D–F), 120 µm; 
20 µm in (G–L).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  7
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FIGURE 2 | Photomicrographs from a section double stained for anti-Aβ 
and NeuN, showing the pattern of immunostaining in layer I and in the 
white matter of the temporal cortex of patient P2. (A) Panoramic view 
showing the cortical layers and white matter. (B,F) Low- and high-magniﬁ  cation 
of layer I, illustrating a non-cored neuritic and a cored neuritic plaque. (C,G), 
(D,H), and (E,I) are low- and high-magniﬁ  cations of the boxed areas in the white 
matter in (A), respectively. Arrows in (B–E) point out plaques (B–D) or a neuron 
(E) also shown at higher magniﬁ  cation in (F–I), respectively. Note that in the 
superﬁ  cial white matter (C,D) there are numerous plaques, whereas in the deep 
white matter (E) no or very few plaques are present. (F–H) Cored neuritic, 
diffuse and non-cored neuritic plaques, respectively. Scale bar, 100 µm in (A); 
50 µm in (B–E); 25 µm in (F–I).
FIGURE 3 | Photomicrographs from sections double stained for anti-Aβ and 
NeuN showing the pattern of immunostaining in the CA1 of patient P3 (A–C) 
and patient P1 (D–F). (B,C) and (E,F) are successive higher magniﬁ  cations of the 
boxed areas in (A,B) and (D,E), respectively. In these microscopic ﬁ  elds there are 
no plaques in patient P3, whereas in patient P1 a large number of plaques are 
observed. Scale bar, 100 µm in (A,D); 50 µm in (B,E); 20 µm in (C,F).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  8
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that were in contact with plaques labeled with Thioﬂ  avine-S, and 
which in turn were innervated by GABAergic terminals recognized 
by antibodies against the GAT-1 or the VGAT (Minelli et al., 1995, 
2003; Yan et al., 1997). As previously described, GAT-1 and VGAT 
immunoreactivity was evident in puncta around the cell bodies and 
in the neuropil of the normal human and mouse cerebral cortex, 
either that derived from control material or from cortical regions 
without plaques. However, the part of the neuron’s membrane 
(mainly pyramidal cells) that is in contact with the plaques lacks 
GABAergic perisomatic terminals. Indeed, of the several hundred 
neurons that we found to come into contact with plaques, in no cases 
were perisomatic terminals found at the surface of the neuron that 
was directly touching the plaque. We veriﬁ  ed this observation by 
analyzing the z-projections of optical sections of neurons in contact 
with plaques from the human (n = 17) and mouse (n = 6) cerebral 
cortex. In these experiments, these neurons were partially or com-
pletely “disconnected” at the perisomatic level (Figure 7).
Electron microscopy
The relationship between neurons and plaques was further examined 
using a correlative light and electron microscopy protocol (DeFelipe 
and Fairen, 1993), which was applied to semithin (2 µm) plastic sec-
tions with neurons in contact with plaques (n = 13, Figures 8 and 9). 
We examined the cerebral cortex from both human and transgenic 
mice from which similar results were obtained. However, due to the 
better preservation of the tissue we focused on the ultrastructural 
analysis of the mouse cerebral cortex. As described previously (Kidd, 
1964; Luse and Smith, 1964; Terry et al., 1964), cored  neuritic plaques 
consist of three more-or-less spherical areas. There is a central area 
that contained a core of electron dense ﬁ  brillar Aβ components, 
and this was surrounded by a second area made up of a light ring 
of glial processes. No synapses were observed in these two areas. 
Surrounding this second domain was a region with more diffuse 
limits that contained dystrophic neurites that were intermingled with 
the apparently normal neuropil where synapses could be observed. 
In general, non-cored neuritic and diffuse plaques had similar 
ultrastructural characteristics to cored neuritic plaques, although 
the Aβ components did not form a dense core and the light ring 
of glial processes was also absent. Within these plaques no or very 
few synapses were observed, whereas synapses were present in the 
periphery. Importantly, although only GABAergic terminals estab-
lish axo-somatic synapses (DeFelipe and Fariñas, 1992), both the 
glutamatergic and GABAergic terminals typically found in the peri-
somatic region (see Merchan-Perez et al., 2009) were excluded from 
the regions of the neuronal somata and proximal processes in con-
tact with the plaques. Indeed, the direct apposition of dystrophic or 
ﬁ  brillar Aβ plaque components precluded the establishment of these 
synapses (Figures 8E, 9B and 10A). However, the neuronal somata in 
contact with the plaques looked normal, with a normal complement 
of cytoplasmic organelles (Figures 9C and 10A). Furthermore, both 
glutamatergic and GABAergic perisomatic terminals were present on 
the parts of the somata or proximal processes of these neurons that 
were not in contact with the plaques, and the GABAergic terminals 
established normal looking symmetric synapses (Figure 10B).
FIGURE 4 | (A) Low-power photomicrograph from a section double stained for 
anti-Aβ and NeuN, showing the pattern of immunostaining in layers I–VI of the 
neocortex of an APP/PS1 transgenic mouse. (B) Higher magniﬁ  cation of the 
boxed area in (A). (C–E) Examples of diffuse, cored neuritic and non-cored 
neuritic plaques, respectively. Scale bar, 200 µm in (A); 100 µm in (B); 50 µm 
in (C–E).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  9
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DISCUSSION
We can draw two main conclusions from the data generated in this 
study. Firstly, a high proportion of plaques are in contact with the 
somata and proximal processes of neurons. Secondly, the mem-
brane of the neuronal somata in contact with the plaque lacked 
perisomatic terminals.
ASSOCIATION BETWEEN DIFFERENT TYPES OF PLAQUES 
WITH NEURONS
The relationship between different types of plaques and neuronal 
cell bodies has been addressed in relatively few studies. For example, 
in one study over 50% of non-cored neuritic plaques present in the 
hippocampal formation and the parahippocampal gyri of ﬁ  ve AD 
cases were associated with neurons (Pappolla et al., 1991). When 
diffuse plaques were examined in the superior temporal gyrus of 
four patients with Down’s syndrome, the vast majority of plaques 
had at least one neuronal cell body within or immediately adjacent 
to the plaque (Allsop et al., 1989). Finally, in a study of four patients 
with Down’s syndrome that focused on the parahippocampal gyrus 
and the lateral occipitotemporal gyrus, diffuse deposits were more 
frequently in contact with neurons than non-cored neuritic plaques 
(Armstrong, 1995).
In the present study, we found that the plaques in AD patients 
were very frequently associated with neurons, particularly in the 
case of diffuse and cored neuritic plaques and less so for non-
cored neuritic plaques. Furthermore, we observed little variation 
FIGURE 5 | (A) Bar diagram illustrating the percentage of the different types of 
plaques (diffuse, non-cored neuritic, and cored neuritic) in contact with neurons 
by cortical layers in the neocortex of AD patients. (B) Bar diagram illustrating the 
percentage of plaques (all types) in contact with neurons in different cortical 
areas (areas 10, 17 , 24 and 20) of patients P1, P2 and P3.  (C) Bar diagram 
illustrating the percentage of the different types of plaques in contact with 
neurons by cortical layers in the neocortex of transgenic mice (see 
Tables 3 and 4 for statistical comparisons).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  10
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in the proportion of plaques that were in contact with neurons 
in different cortical regions and patients. In transgenic mice, 
plaques were also frequently associated with neurons and this 
phenomenon was also relatively homogeneous in all the mice ana-
lyzed. In all cases, the proportion of non-cored neuritic plaques 
in contact with neurons was always slightly higher or equivalent 
to those observed in the neuropil, whereas cored neuritic and 
diffuse plaques were more commonly observed in the neuropil 
than in contact with neurons.
We wondered whether the relationship between the deposits of Aβ 
and the somata of neurons might be associated with the pathogen-
esis of AD. A large proportion of plaques are in contact with neurons 
and indeed, it has been proposed that Aβ could be released from the 
somata of neurons (Allsop et al., 1989; Gouras et al., 2000; D’Andrea 
et al., 2001; Takahashi et al., 2002). The fact that plaques are also 
frequently observed in the neuropil could indicate that those plaques 
in contact with neurons would eventually kill these neurons. Thus, 
plaques in the neuropil could represent a ﬁ  nal pathogenic stage. In 
Table 3 | Statistical comparisons (p < *0.05, **0.01, ***0.001) of the contact between neurons and different types of plaques in cortical layers I–VI, 
and in the superﬁ  cial and depth white matter of AD patients (SWM and DWM, respectively).
 Layer  I  Layer II  Layer III  Layer IV  Layer V  Layer VI  SWM  DWM
LAYER I
Diffuse –  *  *  n.s.  *  n.s.  n.s.  n.s.
Non-cored –  **  **  n.s.  n.s.  **  n.s.  n.s.
Cored –  n.s.  n.s. n.s. n.s.  n.s.  n.s.  n.s.
Total – ***  ***  ***  ***  ***  n.s.  n.s.
LAYER II
Diffuse n.s. –  n.s.  n.s.  n.s. n.s.  n.s.  ***
Non-cored n.s.  –  n.s.  n.s.  n.s.  n.s.  n.s.  ***
Cored n.s.  –  n.s. n.s. n.s.  n.s.  n.s.  n.s.
Total n.s.  – n.s.  n.s.  n.s.  n.s.  n.s.  ***
LAYER III
Diffuse n.s. n.s. –  n.s.  n.s. n.s.  n.s.  ***
Non-cored  n.s. n.s. –  n.s.  n.s. n.s.  n.s.  ***
Cored  n.s. n.s. –  n.s.  n.s. n.s.  n.s.  n.s.
Total  n.s. n.s. –  n.s.  n.s. n.s.  *  ***
LAYER IV
Diffuse n.s. n.s. n.s.  –  n.s. n.s.  n.s.  **
Non-cored  n.s. n.s. n.s.  –  n.s. n.s.  n.s.  *
Cored  n.s. n.s. n.s.  –  n.s. n.s.  n.s.  n.s.
Total  n.s. n.s. n.s.  –  n.s. n.s.  n.s.  ***
LAYER V
Diffuse n.s. n.s. n.s.  n.s.  –  n.s.  n.s.  ***
Non-cored  n.s. n.s. n.s.  n.s.  –  n.s.  n.s.  *
Cored  n.s. n.s. n.s.  n.s.  –  n.s.  n.s.  n.s.
Total  n.s. n.s. n.s.  n.s.  –  n.s.  n.s.  ***
LAYER VI
Diffuse n.s. n.s. n.s.  n.s.  n.s. –  n.s.  n.s.
Non-cored  n.s. n.s. n.s.  n.s.  n.s. –  n.s.  ***
Cored  n.s. n.s. n.s.  n.s.  n.s. –  n.s.  n.s.
Total  n.s. n.s. n.s.  n.s.  n.s. –  n.s.  ***
SWM
Diffuse n.s. n.s. n.s.  n.s.  n.s. n.s.  –  n.s.
Non-cored  n.s. n.s. n.s.  n.s.  n.s. n.s.  –  n.s.
Cored  n.s. n.s. n.s.  n.s.  n.s. n.s.  –  n.s.
Total  n.s. n.s. n.s.  n.s.  n.s. n.s.  –  n.s.
DWM
Diffuse n.s. n.s. n.s.  n.s.  n.s. n.s.  n.s.  –
Non-cored  n.s. n.s. n.s.  n.s.  n.s. n.s.  n.s.  –
Cored  n.s. n.s. n.s.  n.s.  n.s. n.s.  n.s.  –
Total  n.s. n.s. n.s.  n.s.  n.s. n.s.  n.s.  –
n.s., Not signiﬁ  cant.Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  11
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turn, this might help to explain the loss of neurons reported in AD 
patients. However, although the percentage of plaques associated 
to neurons was also very high in the transgenic mice, no neuronal 
loss has been found in these animals (Irizarry et al., 1997a,b; Knafo 
et al., 2009a). Thus, this relationship would seem to be non-speciﬁ  c 
and that the large proportion of plaques associated with neurons 
might be explained by the relatively large size of plaques and the 
high density of neurons. This is in line with the observation that the 
percentage of plaques associated with neurons is low in layer I or in 
the WM adjacent to layer VI, where neurons are relatively sparse. 
However, if this were the case then there would be an equal chance 
for all types of plaques to come into contact with neurons in any 
given cortical area. We found that non-cored neuritic plaques are 
less frequently associated with neurons in AD patients, as was the 
case for diffuse and cored neuritic plaques in transgenic mice. Thus, 
whether there is a direct relationship between the soma of neurons 
and plaques remains to be elucidated, although it certainly does not 
seem to be the case for all types of plaques.
LOCAL TOXIC EFFECTS OF Aβ
The neurons we found in contact with plaques in the mouse 
  cerebral cortex do not seem to have any sign of abnormalities at 
the level of the cell body. In addition, the portions of the soma of 
these neurons that were not in contact with the plaques  established 
typical synapses, whereas the region in direct contact with the 
plaques lacks synapses. Thus, the direct contact of the plaque with 
the cell body does not induce perisomatic disconnection further 
away from the contact domain. This is interesting since plaques 
induce clear morphological alterations of those dendrites that are 
in contact with Aβ (Tsai et al., 2004; Spires et al., 2005). Indeed, 
in the same transgenic mice as those used in the present study we 
have recently shown that dendrites in contact or passing through 
Aβ plaques suffer alterations that include the sprouting of spines 
on dendrites contacting Aβ plaques, the loss of dendritic spines 
and the thinning of dendritic shafts passing through Aβ plaques 
(Knafo et al., 2009a,b). Since dendritic spines represent the main 
postsynaptic elements of excitatory glutamatergic synapses in the 
cerebral cortex (Gray, 1959; Colonnier, 1968), the loss or morpho-
logical alteration of spines provoked by plaques in the neuropil may 
be related to local dampening or alterations to the glutamatergic 
system. However, plaques in contact with neurons suffer alterations 
to the GABAergic system (see below). Thus, our results suggest that 
dendrites are more susceptible to the toxic effect of Aβ than the 
cell body and that this may have important consequences in the 
function of   cortical circuits.
POSSIBLE FUNCTIONAL SIGNIFICANCE OF THE RELATIONSHIP OF 
PLAQUES WITH THE PERISOMATIC REGIONS OF NEURONS
It has been proposed that the Aβ pathology progresses in a neu-
rotransmitter-speciﬁ  c manner, such that cholinergic terminals are 
the most vulnerable, followed by the glutamatergic terminals and 
ﬁ  nally, the GABAergic terminals (Bell et al., 2003). Indeed, it has 
been suggested that GABAergic circuits in the cerebral cortex of 
AD are relatively well preserved when compared with circuits that 
use other neurotransmitters systems (Young, 1987; Lowe et al., 
1988; Reinikainen et al., 1988; Ferrer et al., 1991; Hof et al., 1991; 
Nägga et al., 1999; Rissman et al., 2007). However, alterations of 
neurons labeled for parvalbumin were identiﬁ  ed in the cerebral 
cortex of AD patients in several studies (Fonseca et al., 1993; 
Solodkin et al., 1996; Brady and Mufson, 1997; Mikkonen et al., 
1999), which are responsible for most of the GABAergic pericel-
lular innervation of pyramidal cells (basket and chandeliers cells). 
Irrespective of this possible pathological course, we ﬁ  nd that the 
perisomatic region of the neurons (mostly pyramidal neurons 
since they represent the vast majority of cortical neurons) that is 
in contact with plaques is free of glutamatergic and GABAergic 
perisomatic terminals. We don’t know whether this is simply due 
to the interposition of dystrophic neurites or other pathological 
components of the plaques between the axon terminals and their 
targets, or whether axon terminals are not present because they 
have degenerated or they have been eliminated by glial phago-
cytosis induced by the proximity of the plaques (“synaptic strip-
ping”: see Blinzinger and Kreutzberg, 1968; Moran and Graeber, 
2004). Whatever the cause the ﬁ  nal result would be local synap-
tic disconnection. In general, the soma,   proximal dendrites and 
the axon initial segment only establish   symmetric synapses with 
axon terminals from GABAergic interneurons (mostly basket and 
chandelier cells; DeFelipe and Fariñas, 1992). These perisomatic 
interneurons are presumed to exert a strong inﬂ  uence on the 
output of pyramidal cells (Miles et al., 1996; DeFelipe, 1999). For 
Table 4 | Statistical comparisons and degree of signiﬁ  cance (p < *0.05, 
**0.01, ***0.001) in the percentage of contact with neurons of different 
type of plaques among cortical layers I–VI in APP/PS1 transgenic mice.
  Layer I  Layer II/III  Layer IV  Layer V  Layer VI
LAYER I
Diffuse – *  n.s.  n.s.  n.s.
Non-cored –  *  n.s.  n.s.  *
Cored –  n.s. n.s.  n.s.  n.s.
Total –  ** n.s.  n.s.  **
LAYER II/III
Diffuse n.s.  –  n.s.  n.s.  n.s.
Non-cored n.s.  –  n.s.  n.s.  n.s.
Cored n.s.  –  n.s.  n.s.  n.s.
Total n.s.  –  n.s.  n.s.  n.s.
LAYER IV
Diffuse n.s.  n.s.  –  n.s.  n.s.
Non-cored n.s.  n.s.  –  n.s.  n.s.
Cored n.s.  n.s. –  n.s.  n.s.
Total n.s.  n.s.  –  n.s.  n.s.
LAYER V
Diffuse n.s.  n.s.  n.s.  –  n.s.
Non-cored n.s.  n.s.  n.s.  –  n.s.
Cored n.s.  n.s. n.s.  – n.s.
Total n.s.  n.s.  n.s.  –  n.s.
LAYER VI
Diffuse n.s.  n.s.  n.s.  n.s.  –
Non-cored n.s.  n.s.  n.s.  n.s.  –
Cored n.s.  n.s. n.s.  n.s.  –
Total n.s.  n.s.  n.s.  n.s.  –
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In experimental animals small reductions in the efﬁ  cacy of 
GABA-mediated inhibition can lead to synchronized epileptiform 
activity (Chagnac-Amitai and Connors, 1989) and hence, a loss of 
perisomatic GABA axon terminals may induce epilepsy (see also 
Fonseca et al., 1993). Indeed, in vivo calcium-imaging experiments 
have shown a decrease in activity in about one-third of cortical 
neurons in layer 2/3 of transgenic APP/PS1 mice, yet an increase in 
example, chandelier cells that  exclusively innervate the axon initial 
segment are considered to control the generation and back propa-
gation of action potentials, as well as participating in complex 
activities such as the synchronization of ﬁ  ring patterns of large 
populations of pyramidal cells in different states of conscious-
ness (see Cobb et al., 1995; Miles et al., 1996; DeFelipe, 1999; 
Klausberger et al., 2004; Howard et al., 2005).
FIGURE 6 | Series of confocal images from patient P2 of two plaques (A–F) 
and (G–L) in contact with neurons doubled labeled for NeuN (red) and 
Thioﬂ  avine-S (green). (A–C) Represent stacks of 11 optical sections separated 
by 1 µm in the z-axis (total 9 µm). (D–F) Single optical sections of the plaque 
shown in (A–C) at different levels (6, 8, and 10 steps, respectively). (G–I) 
Represent stacks of 43 optical images separated by 0.50 µm in the z-axis (total 
21 µm). (J–L) Single optical sections at different levels (10, 14, and 21 steps, 
respectively) of the plaque shown in (G–I). Scale bar, 25 µm in (A–L).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  13
Garcia-Marin et al.  Plaques and neuronal somata
FIGURE 7 | Triple ﬂ  uorescence immunohistochemistry to analyze neurons 
visualized with NeuN (green) in contact (some of them indicated with an 
asterisk) with plaques labeled with Thioﬂ  avine-S (blue) that were innervated 
by GABAergic terminals visualized with an antibody against the vesicular 
GABA transporter (VGAT, red, B and D–F) or GABA transporter 1 (GAT-1, red, 
A and C). (A–C), represent stacks of two optical images [10, 15 and 14, 18 steps; 
(A,B), respectively] and three optical images [33, 43, 49 steps; (C)] each step 
separated by 0.2 µm in the z-axis for three different plaques from patient P2. (D–F) 
Single optical sections from the same plane to illustrate the GABAergic innervation 
of neurons in contact with a plaque in a transgenic mouse. Note the lack of 
perisomatic GABA-positive terminals on the surface of the neurons in direct 
contact with the plaques. Scale bar, 30 µm in (A–C); 25 µm in (D–F).
the activity of 21% of neurons when spontaneous calcium bursts 
are measured (Busche et al., 2008). Since numerous studies have 
identiﬁ  ed widespread synaptic dysfunction or loss, even in early 
stages of the disease (Coleman et al., 2004), a decrease in activity 
would not be unexpected. Importantly, hyperactive neurons were 
found directly in the vicinity of Aβ plaques, consistent with the 
loss of perisomatic GABAergic innervation of neurons in contact 
with plaques observed here.
Since our ﬁ  ndings were consistent and they were widespread 
observations in both AD patients and transgenic mice, it is likely that 
similar hyperactive neurons may exist near plaques in AD patients. 
In this regard, it is important to emphasize that AD patients display 
a higher incidence of epileptic seizures (Amatniek et al., 2006). 
Nevertheless, the physiological signiﬁ  cance of hyperactive neurons 
near plaques and its possible relationship with epilepsy is not clear. 
Why do some of AD patients manifest seizures whereas others do 
not? or why do seizures only appear several years after the onset 
of the AD? In a study performed on eight AD patients bearing the 
PS1[E280A] mutation, ﬁ  ve developed epilepsy some years after the 
onset of dementia whereas the remaining three remained seizure-
free (Velez-Pardo et al., 2004). In these AD PS1[E280A] patients, 
two distinct patterns of neuronal loss in the CA1 ﬁ  eld were found 
depending on whether they developed seizures: diffuse–patchy neu-
ronal loss in the non-epileptic AD patients as opposed to a sclerotic-
like neuronal loss in the epileptic patients similar to that found 
typically in the CA1 ﬁ  eld of temporal lobe epilepsy patients with 
hippocampal sclerosis (that is, a large segment of CA1 was practi-
cally devoid of neurons). We would like to emphasize that atrophy 
of the hippocampus is typically considered an early sign of AD but 
this is also typical of patients with temporal lobe epilepsy. Thus, it is 
possible that seizures in AD patients arise as a consequence of a par-
ticular pattern of neuronal loss similar to that observed in epileptic 
patients. The present results suggest that the progressive appearance 
of plaques throughout the cerebral cortex would steadily increase 
the susceptibility to develop and propagate seizures by increasing 
the numbers of hyperactive neurons near plaques. Furthermore, the 
tight spatial association of excitatory axo-dendritic synapses with 
axo-somatic inhibitory terminals around the perisomatic regions 
of pyramidal cells has recently been proposed to be responsible 
for the non-synaptic glutamatergic and GABAergic interactions 
observed in electrophysiological and pharmacological studies (Ren 
et al., 2007), probably due to neurotransmitter spillover (Merchan-
Perez et al., 2009). Since both types of terminals disappear from 
the perisomatic region in contact with the plaques, not only will 
GABAergic transmission in the perisomatic region be affected but 
also, other neurotransmission phenomena that occur in this region. 
Finally, it should also be considered that glial cells display increased 
astrocyte activity in APP/PS1 transgenic mice (Kuchibhotla et al., 
2009), which may also affect the activity of synaptic circuits.
CAVEATS
Animal models are no doubt very useful to examine the different 
morphological, physiological, molecular aspects of AD in depth, 
and to develop anti-Aβ immunotherapies (Brendza et al., 2003; 
Oddo et al., 2003; Brendza and Holtzman, 2006; Eriksen and Janus, 
2007; Götz et al., 2007; Busche et al., 2008; Meyer-Luehmann et al., Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  14
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FIGURE 8 | Correlative light and electron microscopy photomicrographs of 
plaques from the neocortex of an APP/PS1 transgenic mouse. (A–C) 
Photomicrographs of a 2-µm thick semithin plastic section stained with 1% 
toluidine blue showing plaques in the neocortex of an APP/PS1 transgenic mouse. 
(B,C) are successive higher magniﬁ  cations of the boxed area in (A). (D) Low-power 
electron micrographs taken after resection of the semithin section shown in (C), 
illustrating a neuron (asterisk) in contact with a plaque (dn, indicates a dystrophic 
neurite). The same neuron is indicated in (B,C). (E) Higher magniﬁ  cation of (D) to 
illustrate the neuron in contact (asterisk) with the dystrophic neurite (dn). Scale bar, 
150 µm in (A); 50 µm in (B); 12 µm in (C); 10 µm in (D); 2 µm and (E).
FIGURE 9 | (A) Low-power electron micrograph illustrating a neuron 
(asterisk) in contact with a plaque (dn, indicates dystrophic giant neurites 
ﬁ  lled with degenerating organelles). (B) Higher magniﬁ  cation of 
(A) showing that a large portion of the surface of the soma (arrows) is in 
contact with dystrophic neurites (dn). (C) Higher magniﬁ  cation of the 
dystrophic neurites in contact with the membrane of the soma of a 
normal looking neuron. Scale bar, 10 µm in (A); 3.7 µm in (B); 
1 µm in (C).Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  15
Garcia-Marin et al.  Plaques and neuronal somata
FIGURE 10 | (A) Low magniﬁ  cation electron micrograph illustrating a neuron 
(asterisk) in contact with a dystrophic giant neurite (dn). Note that the portion 
of the soma in contact with the dystrophic neurite lacks axo-somatic 
synapses, whereas synapses are established (arrows) in the portion of the 
soma that is not in contact with the dystrophic neurite. (B) Higher 
magniﬁ  cation of the axo-somatic synapses that are typically symmetric 
(GABAergic) synapses (see text for further details). Scale bar, 4 µm in (A); 
1 µm in (B).
2008; Radde et al., 2008). However, the data obtained in animal 
models should be treated with caution when trying to extrapo-
late to the human brain, particularly if we consider that human 
cortical circuits show remarkable differences when compared to 
those of mice (Glezer et al., 1993; Hof et al., 2000b; DeFelipe, 2002; 
Preuss, 2006; DeFelipe et al., 2007). Furthermore, neuroﬁ  brillar 
tangles do not develop in the mouse model of AD used but rather, 
only deposits of Aβ are evident. Thus, there is a clear difference in 
the pathogenesis between human patients and this mouse model. 
Nevertheless, the relationship of the plaques of Aβ deposits and 
neurons was similar, suggesting that the model is useful to study 
this particular aspect of the disease. Finally, the primary quantita-
tive data on the relationship between the neurons and plaques was 
obtained as the number of plaque proﬁ  les and neurons per single 
sections (2-D analysis). As a result, no correction was introduced 
for the possibility that plaques and neurons of different sizes appear Frontiers in Neuroanatomy  www.frontiersin.org  November 2009  | Volume 3  |  Article 28  |  16
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with different probabilities in the sections (i.e., larger plaques or 
neurons will have a greater chance of appearing in more than one 
section). Thus, it is likely that the number of neurons in contact 
with the plaques was underestimated in the 2-D analysis.
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